Formulation and evaluation of ornidazole dental implants for periodontitis
1 Departments of Pharmaceutics, K. L. E. Society's College of Pharmacy, Belgaum-590 010, India 2 Departments of Pharmacognosy, K. L. E. Society's College of Pharmacy, Belgaum-590 010, India
V S Mastiholimath Departments of Pharmaceutics, K. L. E. Society's College of Pharmacy, Belgaum-590 010 India E-mail: [email protected]
Dental implant is a pharmaceutical device in the form of strip with very small loading and size of 0.25 sq cm. For site-specific one-time continuous delivery of ornidazole an antimicrobial compound with excellent activity against anaerobic micro-organism in the treatment of periodontal disease was prepared by solvent casting technique using ethyl cellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose K4M and Eudragit RL-100 with dibutylphthalate as plasticizer. The physicochemical parameters like thickness, weight variation, content uniformity and release characteristics were evaluated The drug release was initially high on day one to achieve immediate therapeutic level of drug in pocket, followed by marked fall in release by day two, and progressive moderate release profile to maintain therapeutic level following anomalous transport mechanism. Formulation V6 released 97.07% of drug at the end of 120 h and was considered as best formulation. In vitro antibacterial activity was carried out on Streptococcus mutans.